Klotho Support Complex.

Klotho is the co-receptor that lets FGF23 signal, and that signal sets the activity of the enzyme converting 25-hydroxyvitamin D to its 1,25 form. The two sit on the same regulatory loop.

The klotho-FGF23 system sets renal phosphate reabsorption through the sodium-phosphate cotransporters. Phosphate load is the input that drives the axis.

Klotho influences calcium handling in the distal tubule through TRPV5 channel stability, so calcium and phosphate balance move together on this axis.

Magnesium is a required cofactor for the hepatic 25-hydroxylase and renal 1-alpha-hydroxylase steps of vitamin D activation, and for vitamin D binding protein handling. Since klotho-focused blends lean on vitamin D receptor signalling, magnesium status sits underneath the whole pathway. This is settled biochemistry rather than a trial result for a klotho blend.

Menaquinone-7 is the cofactor for gamma-carboxylation of matrix Gla protein and osteocalcin, the two proteins that direct where calcium is deposited. The klotho and FGF23 axis governs phosphate handling and vitamin D activation in the same mineral system. Formulators combine them because the mineral handling steps are complementary, not because a combination has been trialled.

NAD-dependent sirtuin signalling and klotho expression are discussed together in the cell biology literature on ageing pathways. Both are laboratory observations about signalling rather than measured human outcomes. The pairing is common in commercial longevity blends and the rationale stays preclinical.

Nicotinamide riboside is phosphorylated by NRK enzymes to NMN and then adenylylated to NAD+, so it raises the substrate pool that sirtuins draw on. Klotho-focused blends include it on that mechanistic basis. Whether raising NAD+ changes klotho expression in a person has not been measured.

Resveratrol is described as a sirtuin pathway activator in cell and animal systems, which is the same signalling family that klotho expression is studied alongside. Human bioavailability of resveratrol is low and variable. Read the pairing as mechanistic.

Pterostilbene is the dimethylated analogue of resveratrol with higher metabolic stability, and it appears in the same blends for the same signalling rationale. No klotho endpoint has been measured with it in humans. The rationale is preclinical.

Sulforaphane activates Nrf2 and the antioxidant response element, a stress-response pathway repeatedly studied alongside klotho expression in cell models. The link is preclinical and the direction in people is unmeasured. Formulators include it for that reason.

Curcumin modulates Nrf2 and NF-kB signalling in laboratory systems, the same stress-response network that klotho research sits in. Its own absorption is poor without a lipid or piperine vehicle, which is a formulation constraint in any blend. This is mechanistic, not clinical.

Astragalus and its cycloastragenol fraction are a standing component of longevity-positioned blends and appear frequently alongside klotho claims. The supporting work is cell-based. Nothing measured in people connects astragalus intake to circulating klotho.

Spermidine is studied as an autophagy inducer in cell and animal models, another pathway that intersects the ageing literature klotho belongs to. Human data is limited to intake associations from cohort work. Label it as association, not cause.

Urolithin A is a gut bacterial metabolite of ellagitannins and is studied for mitochondrial turnover, and only part of the population converts it from dietary precursors. Blends built around cellular ageing pathways combine it with klotho-positioned ingredients. The pairing is mechanistic.

Alpha-lipoic acid and its reduced form recycle glutathione and vitamin C, keeping the cellular redox pool in a reduced state. Klotho-focused blends often include a redox component on that basis. The connection is mechanistic and non-specific.

Phylloquinone drives hepatic gamma-carboxylation of the vitamin K dependent clotting factors and contributes to the same carboxylation chemistry as MK-7, with a shorter half-life and a more liver-directed distribution. In a mineral handling blend it covers a different tissue distribution from MK-7. Anyone on a vitamin K sensitive anticoagulant needs medical advice before adding either.